| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2023 | -13.35% | UBS | → $72 | Initiates Coverage On | → Sell |
| 10/26/2023 | 2.3% | BMO Capital | $83 → $85 | Maintains | Market Perform |
| 10/12/2023 | 17.94% | UBS | $93 → $98 | Maintains | Buy |
| 09/18/2023 | 22.76% | Wells Fargo | → $102 | Initiates Coverage On | → Overweight |
| 07/27/2023 | -27.79% | Credit Suisse | → $60 | Reiterates | Underperform → Underperform |
| 07/05/2023 | 5.91% | UBS | $80 → $88 | Maintains | Buy |
| 06/02/2023 | 11.93% | Truist Securities | $102 → $93 | Maintains | Buy |
| 06/01/2023 | -3.72% | UBS | → $80 | Initiates Coverage On | → Buy |
| 04/28/2023 | -2.52% | BMO Capital | $84 → $81 | Maintains | Market Perform |
| 04/28/2023 | 4.71% | Baird | $103 → $87 | Maintains | Neutral |
| 04/27/2023 | 22.76% | Truist Securities | $110 → $102 | Maintains | Buy |
| 04/27/2023 | -15.75% | Credit Suisse | $75 → $70 | Maintains | Underperform |
| 04/27/2023 | -20.57% | B of A Securities | → $66 | Downgrades | Buy → Underperform |
| 02/09/2023 | 23.96% | Baird | $108 → $103 | Maintains | Neutral |
| 10/27/2022 | 14.33% | BMO Capital | $98 → $95 | Maintains | Market Perform |
| 06/14/2022 | 32.39% | Truist Securities | $150 → $110 | Maintains | Buy |
| 05/27/2022 | 21.55% | Jefferies | $125 → $101 | Maintains | Hold |
| 05/26/2022 | 22.76% | BMO Capital | → $102 | Downgrades | Outperform → Market Perform |
| 05/25/2022 | 8.32% | Credit Suisse | $110 → $90 | Downgrades | Neutral → Underperform |
| 09/16/2021 | 54.05% | BMO Capital | $121 → $128 | Maintains | Outperform |
| 04/29/2021 | 32.39% | Credit Suisse | $89 → $110 | Maintains | Neutral |
| 02/11/2021 | 7.11% | Credit Suisse | $72 → $89 | Maintains | Neutral |
| 06/04/2020 | -13.35% | SunTrust Robinson Humphrey | $60 → $72 | Maintains | Buy |
| 05/04/2020 | -33.81% | Baird | $49 → $55 | Maintains | Neutral |
| 05/01/2020 | -27.79% | SunTrust Robinson Humphrey | $45 → $60 | Maintains | Buy |
| 05/01/2020 | -27.79% | Wells Fargo | $57 → $60 | Maintains | Overweight |
| 05/01/2020 | -9.74% | RBC Capital | $54 → $75 | Maintains | Outperform |
| 05/01/2020 | -39.82% | Credit Suisse | $43 → $50 | Maintains | Neutral |
| 04/20/2020 | -38.62% | BMO Capital | $78 → $51 | Maintains | Outperform |
| 04/14/2020 | -31.4% | Wells Fargo | $80 → $57 | Maintains | Overweight |
| 04/03/2020 | -45.84% | SunTrust Robinson Humphrey | $84 → $45 | Maintains | Buy |
| 02/19/2020 | -21.77% | Jefferies | $70 → $65 | Downgrades | Buy → Hold |
| 02/13/2020 | -4.92% | Baird | $71 → $79 | Maintains | Neutral |
| 02/13/2020 | -24.18% | Credit Suisse | $61 → $63 | Maintains | Neutral |
| 01/09/2020 | -3.72% | Wells Fargo | $75 → $80 | Maintains | Overweight |
| 10/24/2019 | -13.35% | B of A Securities | $73 → $72 | Reiterates | → Buy |
| 04/17/2019 | — | RBC Capital | Initiates Coverage On | → Outperform | |
| 03/12/2019 | -15.75% | Jefferies | → $70 | Initiates Coverage On | → Buy |
What is the target price for ASGN (ASGN)?
The latest price target for ASGN (NYSE: ASGN) was reported by UBS on November 7, 2023. The analyst firm set a price target for $72.00 expecting ASGN to fall to within 12 months (a possible -13.35% downside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ASGN (ASGN)?
The latest analyst rating for ASGN (NYSE: ASGN) was provided by UBS, and ASGN initiated their sell rating.
When is the next analyst rating going to be posted or updated for ASGN (ASGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ASGN, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ASGN was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.
Is the Analyst Rating ASGN (ASGN) correct?
While ratings are subjective and will change, the latest ASGN (ASGN) rating was a initiated with a price target of $0.00 to $72.00. The current price ASGN (ASGN) is trading at is $83.09, which is out of the analyst's predicted range.